Immune Response to a Delayed Second Dose of Oral Cholera Vaccine

PHASE4UnknownINTERVENTIONAL
Enrollment

456

Participants

Timeline

Start Date

July 20, 2022

Primary Completion Date

February 1, 2024

Study Completion Date

July 1, 2024

Conditions
CholeraVibrio Cholerae Infection
Interventions
BIOLOGICAL

Delayed second dose of oral cholera vaccine, Euvichol-Plus

The intervention arms (6 and 12 months) will modify the recommended interval for administration of the second vaccine dose, which will be extended to 6 and 12 months according to the intervention arm.

BIOLOGICAL

Oral cholera vaccine, Euvichol-Plus, according to manufacturer notice

"Euvichol-Plus, a WHO prequalified oral cholera vaccine, contains modified killed whole cell vaccine of formalin killed Vibrio cholerae strains of O1 Inaba, O1 Ogawa and O139.~In the control arm, participants will receive the Euvichol-Plus following the manufacturer recommendations: two doses administered orally 14 days apart for individuals aged ≥1 year."

Trial Locations (1)

Unknown

Dixinn, Conakry

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Ministry of Health, Guinea

OTHER_GOV

collaborator

Massachusetts General Hospital

OTHER

collaborator

Médecins Sans Frontières, Belgium

OTHER

lead

Epicentre

OTHER